Determining Clinically Meaningful Decline in Preclinical Alzheimer Disease

Neurology - United States
doi 10.1212/wnl.0000000000007831
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

The Course of Cognitive Impairment in Preclinical Alzheimer Disease

Archives of Neurology
2000English

Predicting the Rate of Cognitive Decline in Alzheimer Disease

Alzheimer Disease and Associated Disorders
PsychiatryClinical PsychologyGerontologyGeriatricsMental Health
2016English

Ushering in the Study and Treatment of Preclinical Alzheimer Disease

Nature Reviews Neurology
Molecular NeuroscienceNeurologyCellular
2013English

Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer’s Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2015English

Altered Lysosomal Proteins in Neural-Derived Plasma Exosomes in Preclinical Alzheimer Disease

Neurology
Neurology
2015English

Premorbid Reading Activity and Patterns of Cognitive Decline in Alzheimer Disease

Archives of Neurology
2000English

Is Difficult Asthma Still Clinically Meaningful?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2006English

Differences Between Pick Disease and Alzheimer Disease in Clinical Appearance and Rate of Cognitive Decline

Archives of Neurology
2000English

Short-Term Clinical Outcomes for Stages of NIA-AA Preclinical Alzheimer Disease

Neurology
Neurology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy